Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 175

Results For "SEC"

2503 News Found

Avantor to create a new manufacturing hub in Singapore
News | May 05, 2022

Avantor to create a new manufacturing hub in Singapore

The new hub, which brings Avantor solutions closer to regional customers and strengthens global supply chain capabilities, will be fully operational early next year


Merck invests $110 million to expand production site in China
News | May 05, 2022

Merck invests $110 million to expand production site in China

Company will expand the existing production site in Wuxi to significantly increase biopharma single-use assemblies and custom design capabilities


14.9 million excess deaths associated with the Covid-19 pandemic in 2020 and 2021
News | May 05, 2022

14.9 million excess deaths associated with the Covid-19 pandemic in 2020 and 2021

The report has estimated 4.74 million deaths for India in 2020 and 2021,


Scipio bioscience announces its revolutionary Asteria single-cell RNA-seq kit
Biotech | May 04, 2022

Scipio bioscience announces its revolutionary Asteria single-cell RNA-seq kit

At an affordable price, a researcher can process fresh samples of 10,000 cells immediately with a stable stopping point within two hours, simplifying sample management at the laboratory and limiting transcriptional changes


New study links gut microbiota strains with more severe strokes and poorer post-stroke recovery
Healthcare | May 04, 2022

New study links gut microbiota strains with more severe strokes and poorer post-stroke recovery

The study, presented at the European Stroke Organisation Conference (ESOC 2022) pinpointed specific groups of bacteria associated with poorer neurological recovery from ischaemic stroke both in the acute phase (24 hours) and after three months


Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets including India
Biotech | May 04, 2022

Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets including India

Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication


Pfizer sets up global drug development centre in Chennai
News | May 04, 2022

Pfizer sets up global drug development centre in Chennai

The facility is among 12 centres established worldwide, and the first in Asia


NHA enlists Pristyn Care as health tech partner for Ayushman Bharat Digital Mission
Healthcare | May 02, 2022

NHA enlists Pristyn Care as health tech partner for Ayushman Bharat Digital Mission

ABDM is a critical integration that leverages an open, interoperable, standards-based digital system that is secure, and maintains confidentiality and privacy of health-related personal information


Sage Therapeutics and Biogen initiate rolling submission of New Drug Application for Zuranolone
Biotech | May 02, 2022

Sage Therapeutics and Biogen initiate rolling submission of New Drug Application for Zuranolone

The companies expect to complete the submission of the NDA for treatment of MDD in the second half of 2022; associated filing for postpartum depression is anticipated in the first half of 2023


Intravacc signs an exclusive license agreement with Zhifei Lvzhu Biopharmaceutical
Biotech | May 02, 2022

Intravacc signs an exclusive license agreement with Zhifei Lvzhu Biopharmaceutical

Avacc 3 has significant advantages over existing whooping cough vaccines